Dr. Daniel Peterson, MD
Claim this profileAustin Neurosurgeons
Studies Degenerative Disc Disease
Studies Lumbar Spine Disease
5 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials Daniel Peterson, MD is currently running
Vagus Nerve Stimulation
for Rheumatoid Arthritis
The RESET-RA study will assess the safety and efficacy of the SetPoint System (study device) for the treatment of adult patients with active, moderate to severe rheumatoid arthritis who have had an inadequate response or intolerance to biologic or targeted synthetic Disease-Modifying Anti-Rheumatic Drugs (DMARDs). The study device contains a miniaturized stimulator (implant) that is surgically placed under general anesthesia on the vagus nerve through a small incision on the left side of the neck (implant procedure). The study will enroll 250 subjects at 40 sites. All eligible subjects will undergo the implant procedure. Half of the subjects will receive active stimulation (treatment) and the other half will receive non-active stimulation (control). After completing primary endpoint assessments at Week 12, there will be a one-way crossover of control subjects to active stimulation and a 180-week open-label follow-up with all subjects (treatment and control) receiving active stimulation to evaluate long-term safety.
Recruiting1 award Phase 34 criteria
coflex® Interlaminar Stabilization
for Spinal Stenosis
This trial evaluates the safety and effectiveness of the coflex® device for patients with spinal stenosis and low back pain. The device is a small implant that helps stabilize the spine and relieve nerve pressure. The study aims to see how well it works over an extended period. The Coflex device has been studied extensively for its effectiveness in treating lumbar spinal stenosis and degenerative lumbar diseases, with multiple studies showing its long-term efficacy and safety.
Recruiting1 award N/A8 criteria
More about Daniel Peterson, MD
Clinical Trial Related6 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Daniel Peterson, MD has experience with
- OSTEOAMP
- Infuse
- Coflex® Interlaminar Technology
- Decompression
- Ampligen
- SetPoint System
Breakdown of trials Daniel Peterson, MD has run
Degenerative Disc Disease
Lumbar Spine Disease
Lumbar Spine Instability
Spondylolisthesis
Lumbar Spondylolisthesis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Daniel Peterson, MD specialize in?
Daniel Peterson, MD focuses on Degenerative Disc Disease and Lumbar Spine Disease. In particular, much of their work with Degenerative Disc Disease has involved treating patients, or patients who are undergoing treatment.
Is Daniel Peterson, MD currently recruiting for clinical trials?
Yes, Daniel Peterson, MD is currently recruiting for 3 clinical trials in Austin Texas. If you're interested in participating, you should apply.
Are there any treatments that Daniel Peterson, MD has studied deeply?
Yes, Daniel Peterson, MD has studied treatments such as OSTEOAMP, Infuse, coflex® Interlaminar Technology.
What is the best way to schedule an appointment with Daniel Peterson, MD?
Apply for one of the trials that Daniel Peterson, MD is conducting.
What is the office address of Daniel Peterson, MD?
The office of Daniel Peterson, MD is located at: Austin Neurosurgeons, Austin, Texas 78746 United States. This is the address for their practice at the Austin Neurosurgeons.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.